Skip to main content
Clinical Trials/JPRN-UMIN000022275
JPRN-UMIN000022275
Not yet recruiting
未知

Basic research aiming for clinical application of 5-aminolevulinic acid in musculoskeletal sarcomas - Basic research aiming for clinical application of 5-ALA in musculoskeletal sarcomas

Saitama Medical University International Medical Center0 sites20 target enrollmentJanuary 1, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
bone and soft tissue sarcomas
Sponsor
Saitama Medical University International Medical Center
Enrollment
20
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 1, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Having difficulty in taking medication 2\. Still having severe adverse effects of previous treatment for sarcomas 3\. Having un\-controlled infection 4\. Severe complications, such as malignant hypertension, severe congestive heart failure, myocardial infarction within 3 months, terminal cirrhosis, un\-controlled diabetes, severe pulmonary fibrosis, active interstitial pneumonia 5\. Allergy to porphyrin\-related substances 6\. Porphyria 7\. Other active cancer including hematologic malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials